|1.||Young, Stephen G: 5 articles (05/2009 - 02/2002)|
|2.||Sassolas, Agnès: 4 articles (10/2014 - 07/2011)|
|3.||Xie, Yan: 4 articles (03/2014 - 02/2006)|
|4.||Davidson, Nicholas O: 4 articles (03/2014 - 02/2006)|
|5.||Hamsten, Anders: 3 articles (02/2014 - 03/2008)|
|6.||Hooper, Amanda J: 2 articles (01/2015 - 10/2014)|
|7.||Burnett, John R: 2 articles (01/2015 - 10/2014)|
|8.||Gottrand, Frederic: 2 articles (10/2014 - 03/2012)|
|9.||Di Filippo, Mathilde: 2 articles (10/2014 - 03/2012)|
|10.||Samson-Bouma, Marie Elisabeth: 2 articles (10/2014 - 03/2012)|
01/01/2014 - "Young (8-10 week) Mttp-IKO mice have improved survival when subjected to a murine model of Pseudomonas aeruginosa-induced sepsis. "
01/01/2012 - "Rather, Mttp-IKO mice exhibited protection against sepsis-associated decreases in villus length and intestinal proliferation and were also protected against increased intestinal apoptosis, both central features in control septic mice. "
01/01/2014 - "The purpose of this study was to determine whether age impacts outcome in Mttp-IKO mice subjected to sepsis. "
01/01/2012 - "Intestine-specific Mttp deletion decreases mortality and prevents sepsis-induced intestinal injury in a murine model of Pseudomonas aeruginosa pneumonia."
01/01/2012 - "Serum IL-6 levels, a major predictor of mortality in human and mouse models of sepsis, were elevated 8-fold in septic control mice but remained unaltered in septic Mttp-IKO mice. "
|2.||Weight Loss (Weight Reduction)
03/01/2014 - "Following 2 weeks of LD feeding, 73% of WT and 100% of L-Fabp KO mice developed gallstones versus 18% of Mttp-LKO and 23% of DKO mice. "
03/01/2014 - "Hepatic Mttp deletion reverses gallstone susceptibility in L-Fabp knockout mice."
12/01/2006 - "The incidence of gallstones decreased from 90% in control mice to 33% in Mttp(Delta/Delta) mice after 8 weeks of a lithogenic diet (P < .0001). "
03/01/2014 - "Other studies demonstrated that liver-specific deletion of microsomal triglyceride transfer protein (Mttp-LKO) reduced LD-induced gallstone formation by increasing biliary phospholipid secretion. "
03/01/2014 - "We conclude that liver-specific Mttp deletion not only eliminates apical lipoprotein secretion from hepatocytes but also attenuates canalicular cholesterol secretion, which in turn decreases LD-induced gallstone susceptibility. "
|4.||Myocardial Ischemia (Ischemic Heart Diseases)
01/01/2013 - "Previous studies investigating the effect of MTTP on ischemic heart disease have produced inconsistent results. "
01/01/2010 - "Allele-specific regulation of MTTP expression influences the risk of ischemic heart disease."
01/01/2010 - "Promoter polymorphisms in microsomal triglyceride transfer protein (MTTP) have been associated with decreased plasma lipids but an increased risk for ischemic heart disease (IHD), indicating that MTTP influences the susceptibility for IHD independent of plasma lipids. "
|2.||microsomal triglyceride transfer protein
|3.||thymidine 5'-triphosphate (TTP)
|4.||Apolipoproteins B (ApoB)
|8.||Proteins (Proteins, Gene)
|9.||Apolipoprotein B-100 (Apo B 100)
|1.||Drug Therapy (Chemotherapy)